TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Aratana Therapeutics Inc (NASDAQ: PETX) Investor Securities Class Action Lawsuit 02/06/2017

  • If you purchased shares of Aratana Therapeutics Inc, you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

June 11, 2018 - The court granted defendants' motion to dismiss with prejudice. October 6, 2017 - Defendants filed a motion to dismiss. August 7, 2017 - The lead plaintiffs filed an amended complaint on behalf of investors who purchased Aratana Therapeutics Inc (NASDAQ: PETX) common shares between March 16, 2015 and March 13, 2017. The lead plaintiffs allege that the defendants viol...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: